FIGURE

Figure 4

ID

ZDB-FIG-220302-13

Publication

Copmans et al., 2022 - From the North Sea to Drug Repurposing, the Antiseizure Activity of Halimide and Plinabulin

Other Figures

All Figure Page

Back to All Figure Page

Figure 4

Behavioral antiseizure analysis of the R- and S-enantiomers of halimide in the zebrafish PTZ seizure model. (A) Chemical structures of (S)-halimide and (R)-halimide. (B–E) Antiseizure activity of (S)-halimide (B,C) and (R)-halimide (D,E) in the zebrafish pentylenetetrazole (PTZ) seizure model after 2 h of incubation. Behavioral data is expressed in mean actinteg units per 5 min (±SEM) during the 30 min recording period (B,D) and over consecutive time intervals (C,E). Data is normalized against the vehicle (VHC) + PTZ control condition (C,E). Data are pooled from two independent experiments with a total of 20 replicate wells for VHC + VHC, VHC + PTZ, and compound + PTZ conditions, and 11–12 replicate wells for compound + VHC conditions. Statistical analysis: (B,D) one-way ANOVA with Dunnett’s multiple comparison test, (C,E) two-way ANOVA with Dunnett’s multiple comparison test (GraphPad Prism 9, San Diego, CA, USA). Significance levels: * p ≤ 0.05; ** p ≤ 0.01; *** p ≤ 0.001; **** p ≤ 0.0001.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Pharmaceuticals (Basel)